FDA approves Novo Nordisk’s Sogroya® as first and only once-weekly, long-acting growth hormone for three additional pediatric indications
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…
On Dec. 29, 1995, the Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved by the…
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…
In 1978, University of California, Berkeley (UC-Berkeley) scientist Choh Hao Li discovers Beta-endorphin, a substance produced in the…
On Jan. 6, 1971, research scientists at the University of California Berkeley announced the first synthetic production of…
In 1920, H. McLean Evans and Joseph Abraham Long at the University of California announced they had discovered…